Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.
In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.
Cardiovascular disease is a general term that refers to many different types of heart problems.Heart disease is the ...
A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
For over two decades, a ‘treatment-risk paradox’ has been described in older adults with cardiovascular disease, with ...
The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...
The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...
14d
MedPage Today on MSNSafer Antiplatelet Routines, Non-Statin Meds Feature in New Heart Attack GuidelinesIn updated American recommendations for the management of acute coronary syndrome (ACS), bleeding reduction strategies on antiplatelet therapy are embraced, as are non-statin lipid-lowering therapies ...
A heart attack, or myocardial infarction, happens when blood flow to the heart becomes blocked. Classic symptoms include chest pain, shortness of breath, and heightened anxiety, but some people may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results